Dr. Azim Lateeb

Azeem Latib

Interventional cardiologist / Cardiologist
Montefiore Medical Center Moses Division - New York, United States of America

Latest contributions

In what situation is emergency transcatheter valve intervention a valid alternative to surgery?

16 Nov 2025 – From PCR London Valves 2025

Azeem Latib and Giuseppe Tarantini discuss how transcatheter therapies are increasingly used to treat critically ill patients with severe valvular disease and cardiogenic shock—patients once considered untreatable. They highlight cases ranging from severe AS with ACS to acute papillary muscle rupture and acute severe regurgitation, showing...

In what situation is emergency transcatheter valve intervention a valid alternative to surgery?

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

18 Nov 2025 – From PCR London Valves 2025

This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

Paravalvular leaks and VSD percutaneous closure - Recorded cases

17 Nov 2025 – From PCR London Valves 2025

Recorded case 1: A 56-year-old female with a prior mechanical mitral valve replacement (Star GK, 2018), permanent AF, and normal LV function presented with recurrent HF admissions due to paravalvular leaks. She was treated with implantation of multiple plugs via a transseptal approach using a Destination...

Paravalvular leaks and VSD percutaneous closure - Recorded cases

Tricuspid repair or replacement - Matching the patient to the procedural strategy

17 Nov 2025 – From PCR London Valves 2025

This session addresses the nuanced decision-making process in selecting appropriate transcatheter tricuspid repair or replacement strategies. It covers the current device landscape, patient selection criteria based on anatomical and clinical factors, and discusses emerging challenges such as pacing lead management, anticoagulation, and outcome definitions.

Tricuspid repair or replacement - Matching the patient to the procedural strategy

Rapid fire on ortothopic TTVR

16 Nov 2025 – From PCR London Valves 2025

This rapid-fire session presents an overview of the latest orthotopic transcatheter tricuspid valve replacement (TTVR) devices. It features concise discussions on multiple innovative systems including Evoque, Laplace, VDyne, Topaz, and Cardiovalve, offering insights into their design characteristics and clinical applications in tricuspid valve disease management.

Mitral TEER - LIVE case

16 Nov 2025 – From PCR London Valves 2025

Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...

Mitral TEER - LIVE Case

Emergency transcatheter valve interventions: alternative therapy or bridge to surgery?

16 Nov 2025 – From PCR London Valves 2025

This session offers a compelling case-based exploration of emergency transcatheter valve interventions, demonstrating their potential as life-saving alternatives or bridges to surgery in high-risk patients. Through detailed clinical scenarios including cardiogenic shock, acute papillary muscle rupture, and severe aortic regurgitation from infective endocarditis, participants gain practical...

Emergency transcatheter valve interventions: alternative therapy or bridge to surgery?

EuroPCR 2025: innovation, clinical trials and education

11 Jun 2025

Discover what D. Milasinovic and A. Latib shared on the takeaways of EuroPCR 2025.

TAVI for bioprosthetic valve failure - LIVE Case

22 May 2025 – From EuroPCR 2025

A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...

TAVI for bioprosthetic valve failure - LIVE Case

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

21 May 2025 – From EuroPCR 2025

Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

New devices for structural interventions

21 May 2025 – From EuroPCR 2025

Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.

New devices for structural interventions

Mitral hotline: new devices

20 May 2025 – From EuroPCR 2025

Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...

Mitral hotline: new devices

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?

The Jon DeHaan Foundation Award competition

19 May 2025 – From EuroPCR 2025

Witness innovation in action at the Jon DeHaan Foundation Award competition featuring groundbreaking technologies like synchronized diaphragmatic stimulation for heart failure and novel devices for aortic bioprosthesis and interatrial shunting.

The Jon DeHaan Foundation Award competition

Degeneration of TAVI valves: a new target for innovations

19 May 2025 – From EuroPCR 2025

Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.

Degeneration of TAVI valves: a new target for innovations

Heart to Heart Conversations podcasts – expert insights in interventional cardiology, anytime, anywhere

06 Feb 2025

Stay ahead in interventional cardiology with Heart-to-heart podcasts, the audio companion to our acclaimed webinar series.

Focus on Innovation - PCR London Valves 2024

Azeem Latib and Jose Calle Gordo reflect on the PCR London Valves 2024 programme, which showcased groundbreaking advancements in valve technology. Highlights included sessions on transforming ideas into market-ready devices, intimate small-group discussions fostering meaningful exchange, and a hands-on innovation session to explore new devices. The...

Focus on Innovation - PCR London Valves 2024

Best of science and education in cardiovascular interventional medicine in 2024

16 Dec 2024

Dear Colleagues, dear PCR Companions,

As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.

2024 was a record year...

What is the future role of 3D ICE in tricuspid valve intervention?

26 Nov 2024 – From PCR London Valves 2024

Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...

What is the future role of 3D ICE in tricuspid valve intervention?

Transcatheter mitral valve replacement - Are we there yet?

25 Nov 2024 – From PCR London Valves 2024

Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!

Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...

Transcatheter mitral valve replacement - Are we there yet?

New technology for transcather valve replacement - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a series of recorded cases showcasing advanced valve therapies and innovative techniques:

  • A 70-year-old man with Marfan syndrome (treated by Bentall and CABG in 2012), impaired LV function (35%), CRT-D, and symptomatic severe primary MR (A2 prolapse with calcification) underwent implantation of an Intrepid valve under...
New technology for transcather valve replacement - LIVE Case

Voices of innovation: perspectives from the stakeholders

25 Nov 2024 – From PCR London Valves 2024

Curious about how innovation becomes impact? This video is a must-watch! Discover now what drives medical breakthroughs from concept to reality and explore the perspectives of those shaping the future of healthcare.

You’ll gain insights into the challenges innovators face at every stage—breakthrough ideas, market regulation, and...

Voices of innovation: perspectives from the stakeholders

Parading progress in transcatheter valve interventions

25 Nov 2024 – From PCR London Valves 2024

Curious about the future of transcatheter valve interventions? Watch this video to get an exclusive preview of groundbreaking (pre-CE mark) technologies shaping the future of valve repair!

You’ll discover the latest innovations in structural intervention devices, including next-gen technologies like the Mitral Butterfly, Vesalius, MonarQ and Luna...

Parading the progress in transcatheter valve interventions

Innovation for transcatheter tricuspid interventions - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Dive into the world of innovation for transcatheter tricuspid interventions. Discuss the remaining challenges associated with currently available options, capture the central role of imaging guidance, and understand the anatomical selection criteria for transcatheter tricuspid valve replacement. Experience a live case from St. Thomas' Hospital, London,...

Innovation for transcatheter tricuspid interventions

Breaking new ground in mitral valve interventions

24 Nov 2024 – From PCR London Valves 2024

What’s shaping the future of mitral valve therapies? This video from PCR London Valves 2024 unveils groundbreaking late-breaking trials that redefine the possibilities in mitral interventions.

You'll explore real-world insights from the OCEAN-Mitral registry on the MitraClip G4, uncover the link between tricuspid regurgitation and 3-year mortality...

Breaking new ground in mitral valve interventions

A patient with ISR: what is the role of DCB today?

07 Oct 2024

Watch the replay of this webinar to review the mechanisms of ISR and so much more!

Perspectives on drug coated balloons from EuroPCR 2024

16 May 2024 – From EuroPCR 2024

In this roundtable discussion, Azeem Latib and Antonio Colombo discuss the role of drug-coated balloons (DCBs) in their current practice, including their indications, the different types of DCBs, and how to choose between them. They also cover ongoing studies in the US aimed at bringing this...

Perspectives on drug coated balloons from EuroPCR 2024

To repair or to replace the mitral valve: that is the question

16 May 2024 – From EuroPCR 2024

This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...

To repair or to replace the mitral valve: that is the question

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

How to best image the atrioventricular valves?

14 May 2024 – From EuroPCR 2024

This session, in collaboration with the PCR Tricuspid Focus Group, aims to provide a comprehensive understanding of how to image the atrioventricular valves (mitral and tricuspid) to assess their anatomy and pathology. It covers the step-by-step evaluation of the mitral and tricuspid valves using transesophageal echocardiography...

How to best image the atrioventricular valves?